story of the week
Risk of Adverse Drug Reaction While Treating Bacterial Skin Infections and Herpesviridae Infections With Ustekinumab, Secukinumab, and TNF-α Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Acta Dermato-Venereologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
Acta Derm Venereol 2022 Feb 11;[EPub Ahead of Print], L Davidson, JMPA Van den Reek, F Van Hunsel, EMGJ De Jong, BJ KullbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.